Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Trial Holdings's Sloan Ratio for the quarter that ended in Mar. 2026 was 0.00%.
Warning Sign:
When sloan ratio (39.18)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.
As of Mar. 2026, Trial Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Trial Holdings (TSE:141A) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Trial Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Trial Holdings Sloan Ratio % Related Terms
Trial Holdings Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Trial Holdings's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:141A vs WMT, COST, TGT: Sloan Ratio % Comparison
For the Discount Stores subindustry, Trial Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trial Holdings Sloan Ratio % vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, Trial Holdings's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Trial Holdings's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Trial Holdings's Sloan Ratio for the fiscal year that ended in Jun. 2026 is calculated as
Trial Holdings's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 3378 (Jun. 2025 ) + -979 (Sep. 2025 ) + 5036 (Dec. 2025 ) + 1865 (Mar. 2026 ) = 円9,300 Mil.
Trial Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) + 0 (Mar. 2026 ) = 円0 Mil.
Trial Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) + 0 (Mar. 2026 ) = 円0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trial Holdings (TSE:141A) has a Sloan Ratio % of 0.00% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Trial Holdings and its competitors.
Is Trial Holdings' Sloan Ratio % too high?
Trial Holdings' current Sloan Ratio % is 0.00%. Overall, Trial Holdings has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Trial Holdings' Sloan Ratio % compare to WMT and COST?
Trial Holdings' Sloan Ratio % of 0.00% can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Retail - Defensive company?
A good Sloan Ratio % depends on the Retail - Defensive industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Trial Holdings and its competitors. Trial Holdings's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trial Holdings stock overvalued right now?
Trial Holdings (TSE:141A) has a current Sloan Ratio % of 0.00%. The current Sloan Ratio % is 0.00%. Trial Holdings' overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Trial Holdings (TSE:141A), the current Sloan Ratio % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trial Holdings Inc is a holding company. Along with its subsidiaries, it operates in the following reportable segments: Retail Distribution Business and Retail AI Business. The majority of its revenue is generated from the Retail Distribution Business, which operates discount stores across Japan, ranging from small to large, along with medium-sized supercenters. The product lineup of the stores focuses on food (especially fresh foods), and non-food items include daily necessities and hard goods. The Retail AI Business segment is mainly involved in research and development aimed at transforming stores into smart stores, as well as the sale of products and the outsourcing of services related to smart stores. In addition, the group is involved in real estate and resort-related businesses.
39GF Score
Get the complete analysis for TSE:141A
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:141A has been successfully added to your 
